Michael E Carney

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
    Michael E Carney
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah 84198, USA
    Gynecol Oncol 84:36-42. 2002
  2. ncbi request reprint Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer
    Angeles Alvarez Secord
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Box 3079, Duke University Medical Center, Durham, NC 27710, USA
    Int J Clin Oncol 12:31-6. 2007
  3. doi request reprint Current understanding of risk factors for ovarian cancer
    Thanasak Sueblinvong
    Department of Obstetrics and Gynecology, John A Burn School of Medicine, Honolulu, HI 96826, USA
    Curr Treat Options Oncol 10:67-81. 2009
  4. ncbi request reprint Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer
    Laura J Havrilesky
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Gynecol Oncol 88:51-7. 2003
  5. ncbi request reprint Granulosa cell tumor of the ovary: extensive late recurrence after initial occult microscopic disease
    Kimberly K Vesco
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, USA
    Obstet Gynecol 99:888-91. 2002
  6. ncbi request reprint Stage at diagnosis of ovarian cancer in the United States, 1992-1997
    Marc T Goodman
    Cancer Research Center, University of Hawaii, Honolulu, USA
    Cancer 97:2648-59. 2003
  7. pmc Consortium analysis of 7 candidate SNPs for ovarian cancer
    Susan J Ramus
    Translational Research Laboratory, University College London EGA Institute for Women s Health, London, United Kingdom
    Int J Cancer 123:380-8. 2008
  8. doi request reprint Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects
    Galina Lurie
    Cancer Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813, USA
    Epidemiology 19:237-43. 2008
  9. ncbi request reprint Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk
    Galina Lurie
    Cancer Epidemiology Program, Cancer Research Center of Hawaii, Honolulu, HI 96813, USA
    Cancer Epidemiol Biomarkers Prev 16:2566-71. 2007
  10. ncbi request reprint Ovarian cancer hormonal and environmental risk effect
    Christine Vo
    Department of Obstetrics, Gynecology and Women s Health, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813, USA
    Obstet Gynecol Clin North Am 34:687-700, viii. 2007

Collaborators

Detail Information

Publications15

  1. ncbi request reprint A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
    Michael E Carney
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah 84198, USA
    Gynecol Oncol 84:36-42. 2002
    ..To determine the fraction of patients diagnosed with ovarian cancer and seen by a gynecologic oncologist and to compare outcomes with those patients and others who are not seen by a gynecologic oncologist...
  2. ncbi request reprint Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer
    Angeles Alvarez Secord
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Box 3079, Duke University Medical Center, Durham, NC 27710, USA
    Int J Clin Oncol 12:31-6. 2007
    ..The purpose of this study was to evaluate the toxicity profile of weekly low-dose paclitaxel and carboplatin in patients with gynecologic malignancies...
  3. doi request reprint Current understanding of risk factors for ovarian cancer
    Thanasak Sueblinvong
    Department of Obstetrics and Gynecology, John A Burn School of Medicine, Honolulu, HI 96826, USA
    Curr Treat Options Oncol 10:67-81. 2009
    ..The most current understanding of these elements and their respective contribution to the development of this cancer are presented in this chapter...
  4. ncbi request reprint Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer
    Laura J Havrilesky
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Gynecol Oncol 88:51-7. 2003
    ..Combination paclitaxel and carboplatin is a well-established first-line regimen for ovarian cancer. The purpose of this study was to evaluate weekly low-dose paclitaxel and carboplatin in recurrent ovarian or peritoneal cancer...
  5. ncbi request reprint Granulosa cell tumor of the ovary: extensive late recurrence after initial occult microscopic disease
    Kimberly K Vesco
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, USA
    Obstet Gynecol 99:888-91. 2002
    ..Late recurrence can be extensive with initial, clinically undetectable, microscopic granulosa cell tumor of the ovary...
  6. ncbi request reprint Stage at diagnosis of ovarian cancer in the United States, 1992-1997
    Marc T Goodman
    Cancer Research Center, University of Hawaii, Honolulu, USA
    Cancer 97:2648-59. 2003
  7. pmc Consortium analysis of 7 candidate SNPs for ovarian cancer
    Susan J Ramus
    Translational Research Laboratory, University College London EGA Institute for Women s Health, London, United Kingdom
    Int J Cancer 123:380-8. 2008
    ..These null results for SNPs identified from relatively large initial studies shows the importance of replicating associations by a consortium approach...
  8. doi request reprint Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects
    Galina Lurie
    Cancer Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813, USA
    Epidemiology 19:237-43. 2008
    ..Although the protective effect of oral contraceptives (OCs) use against epithelial ovarian cancer is well-established, there remain gaps in our understanding of the contributions of time-related characteristics of OC use to risk...
  9. ncbi request reprint Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk
    Galina Lurie
    Cancer Epidemiology Program, Cancer Research Center of Hawaii, Honolulu, HI 96813, USA
    Cancer Epidemiol Biomarkers Prev 16:2566-71. 2007
    ..1 and OR 5.2, 95% CI 1.6-17.5), but not in Japanese women (OR 1.1, 95% CI 0.6-1.9 and OR 2.3, 95% CI:0.4-12.3). This investigation provides some evidence that polymorphisms in the VDR gene might influence ovarian cancer susceptibility...
  10. ncbi request reprint Ovarian cancer hormonal and environmental risk effect
    Christine Vo
    Department of Obstetrics, Gynecology and Women s Health, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813, USA
    Obstet Gynecol Clin North Am 34:687-700, viii. 2007
    ..This article discusses the different hypotheses and focuses on hormonal and environmental risk factors, as well the chemoprevention of epithelial ovarian cancer...
  11. ncbi request reprint Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer
    Simon A Gayther
    Translational Research Laboratories, University College London, London, United Kingdom
    Cancer Res 67:3027-35. 2007
    ..This study highlights the need for multicenter collaborations for genetic association studies...
  12. ncbi request reprint Calcitonin gene polymorphism CALCA-624 (T/C) and ovarian cancer
    Marc T Goodman
    Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813, USA
    Environ Mol Mutagen 46:53-8. 2005
    ..These preliminary data suggest a strong positive association of the CALCA C allele with the risk of ovarian cancer among some subgroups...
  13. ncbi request reprint Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer
    Abigail W Bushley
    Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813, USA
    Gynecol Oncol 95:672-9. 2004
    ....
  14. ncbi request reprint Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study
    Ko Hui Tung
    Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu 96813, USA
    Am J Epidemiol 158:629-38. 2003
    ..Mucinous tumors, both borderline and invasive, were more common in Asian women than in Caucasian and other women. Our data suggest that histologic types of epithelial ovarian cancer are etiologically distinct...
  15. ncbi request reprint Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk
    Galina Lurie
    Cancer Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii, USA
    Obstet Gynecol 109:597-607. 2007
    ..To estimate the association of the estrogen and progestin potency of combined oral contraceptive pills (OCPs) with epithelial ovarian carcinoma risk...